Arne Leth
University of Copenhagen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arne Leth.
Bone and Mineral | 1988
Jan Pødenphant; B.J. Riis; Julia S. Johansen; Arne Leth; Claus Christiansen
Changes in tetracycline-labelled iliac crest biopsies taken before and after 1 year of treatment with nandrolone decanoate + calcium, 17 beta-estradiol + norethisterone acetate + calcium or placebo were compared with changes in plasma bone Gla protein (pBGP), serum alkaline phosphatase (sAP), whole body retention (WBR) of Technetium-99m-diphosphonate [( 99mTc]DP) and bone mineral content (BMC) of the forearm. Based on a comparison between biopsy and noninvasive results, as well as on evaluation of the variation in the groups, certain guidelines for the use of bone histomorphometry in longitudinal therapeutic trials are suggested. It is proposed that bone biopsy is not used to monitor changes in amount of bone and that evaluation of changes in biopsy evaluated bone turnover is only attempted when the groups are large.
Clinical Pharmacology & Therapeutics | 1983
Ulrik Gerner Svendsen; Hans Ibsen; Sten Rasmussen; Arne Leth; Meta Damkjær Nielsen; Harriet Dige-Petersen; Jørn Giese
Total body potassium content, plasma potassium concentration, blood pressure, and plasma concentrations of renin, angiotensin II, and aldosterone were measured in patients with essential hypertension after a run‐in period of 8 wk on a regimen of hydrochlorothiazide (median dosage 75 mg/day). Patients were then randomly assigned to continued hydrochlorothiazide therapy (group I) or to receive adjunctive treatment with amiloride (group II, median dosage 15 mg/day or 5 mg per 25 mg hydrochlorothiazide) for the following 3 mo. There were no changes in group I patients during 3 mo on hydrochlorothiazide in plasma potassium, total body potassium content, or the renin‐angiotensin‐aldosterone system. Blood pressure was also unchanged. In group II patients addition of amiloride to hydrochlorothiazide induced a rise in plasma and total body potassium of approximately 15% and 4%. The potassium‐retaining effect was maintained throughout the 12‐wk period, although the maximal changes were observed after 8 wk of treatment. Supine blood pressure did not change, but there was a significant decrease in standing systolic blood pressure. There was a marked rise in plasma concentrations of renin, angiotensin II, and aldosterone.
European Journal of Clinical Pharmacology | 1986
Ulrik Gerner Svendsen; Hans Ibsen; Sten Rasmussen; Arne Leth; Meta Damkjær Nielsen; Harriet Dige-Petersen; Jørn Giese
SummaryAfter a run-in period of 8 weeks on a regimen of hydrochlorothiazide (HCT, median dosage 75 mg/day), patients with essential hypertension were randomly allocated to continued hydrochlorothiazide therapy (Group I) or additional treatment with amiloride (Group II, median dosage 15 mg/day, or 5 mg per 25 mg hydrochlorothiazide) for the following 12 weeks. Thereafter all the patients were changed to treatment with a fixed combination tablet containing 5 mg amiloride and 50 mg hydrochlorothiazide (Moduretic), keeping the thiazide dosage unchanged for an additional 12 weeks. In Group I patients there was no change in plasma potassium, total body potassium content or the renin-angiotensin-aldosterone system during the 12 weeks on HCT. When the treatment was changed to Moduretic, significant increases were found of 10% in plasma potassium and 3% in total body potassium content. No important stimulation of the renin-angiotensin-aldosterone system was found. In Group II patients addition of an average of 15 mg amiloride to the hydrochlorothiazide treatment led to significant increases in plasma potassium and total body potassium content of approximately 15% and 4%, respectively. There was also a significant increase in the plasma concentrations of renin, angiotensin II and aldosterone. Reducing the average dose of amiloride to 7.5 mg/day by use of Moduretic did not lead to decrease in plasma potassium or total body potassium content. Plasma concentrations of renin, angiotensin II, and aldosterone were decreased, but the individual changes varied markedly and no significant overall change was found.
Acta Medica Scandinavica | 2009
Sten Rasmussen; Arne Leth; Erik Kjøller; Asger Pedersen
Acta Medica Scandinavica | 2009
Knud H. Olesen; Bjarne Sigurd; Eva Steiness; Arne Leth
Journal of Bone and Mineral Research | 2009
Jan Pødenphant; Julia S. Johansen; Karsten Thomsen; B.J. Riis; Arne Leth; Claus Christiansen
Acta Medica Scandinavica | 2009
J. Fischer Hansen; Arne Leth; S. Dorph; Alf Wennevold
Acta Medica Scandinavica | 2009
Arne Leth; Jørgen Fischer Hansen; Jørgen Meibom
Acta Medica Scandinavica | 2009
Sten Rasmussen; Arne Leth; Hans Ibsen; Meta Damkjær Nielsen; Finn Erland Nielsen; J. Giese
Acta Medica Scandinavica | 2009
Arne Leth; Bjørn Christau; Peter Schnohr; Niels Eske Bruun; Lars Møller